| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |